Phase 2 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing and able to give written agreement to take part (or a legal representative can do this on your behalf)
- You are a woman who has gone through menopause, are aged 50 or older, and have been diagnosed with a specific type of breast cancer called invasive lobular carcinoma (ILC), confirmed by a biopsy, at a stage where the tumor is a certain size and has not spread widely to lymph nodes
- You have already chosen and are healthy enough to have breast-conserving surgery (surgery that removes the tumor but keeps most of the breast) at the time of joining the trial
- Your cancer is a specific subtype where it is driven by the hormone estrogen (ER+) and does not have high levels of a protein called HER2 (HER2-), as confirmed by laboratory tests on the biopsy sample
Who may not be able to join:
- You have previously had breast cancer in the same breast
- Your cancer has spread significantly to many nearby lymph nodes, or has spread to other parts of the body (stage 4)
- Your cancer doctor believes you would be better treated with chemotherapy before surgery
- You are not able to have full breast surgery for any reason, including if your cancer is inoperable or has spread to other parts of the body
- You have an allergy to gadolinium, which is a dye used during breast MRI scans
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Anita SKCCSC(P Mamtani, MD, Memorial Sloan Kettering Cancer Center
Phone: 646-888-6864
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rate of positive surgical margins after breast cancer surgery
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.